Cytotoxic T Cells swarm by homotypic chemokine signalling

  1. Jorge Luis Galeano Niño
  2. Sophie V Pageon
  3. Szun S Tay
  4. Feyza Colakoglu
  5. Daryan Kempe
  6. Jack Hywood
  7. Jessica K Mazalo
  8. James Cremasco
  9. Matt A Govendir
  10. Laura F Dagley
  11. Kenneth Hsu
  12. Simone Rizzetto
  13. Jerzy Zieba
  14. Gregory Rice
  15. Victoria Prior
  16. Geraldine M O'Neill
  17. Richard J Williams
  18. David R Nisbet
  19. Belinda Kramer
  20. Andrew I Webb
  21. Fabio Luciani
  22. Mark N Read
  23. Maté Biro  Is a corresponding author
  1. EMBL Australia, Australia
  2. University of New South Wales, Australia
  3. The University of Sydney, Australia
  4. The Walter and Eliza Hall Institute of Medical Research, Australia
  5. The Children's Hospital at Westmead, Australia
  6. University of Waterloo, Canada
  7. Kids Research, Australia
  8. Deakin University, Australia
  9. Australian National University, Australia
  10. University of Sydney, Australia

Abstract

Cytotoxic T lymphocytes (CTLs) are thought to arrive at target sites either via random search or following signals by other leukocytes. Here, we reveal independent emergent behaviour in CTL populations attacking tumour masses. Primary murine CTLs coordinate their migration in a process reminiscent of the swarming observed in neutrophils. CTLs engaging cognate targets accelerate the recruitment of distant T cells through long-range homotypic signalling, in part mediated via the diffusion of chemokines CCL3 and CCL4. Newly arriving CTLs augment the chemotactic signal, further accelerating mass recruitment in a positive feedback loop. Activated effector human T cells and chimeric antigen receptor (CAR) T cells similarly employ intra-population signalling to drive rapid convergence. Thus, CTLs recognising a cognate target can induce a localised mass response by amplifying the direct recruitment of additional T cells independently of other leukocytes.

Data availability

All data generated or analysed during this study are included in the manuscript and supporting files. Source data files with extensive statistical information have been provided for all figures containing bar, box or violin plots. Complete transcriptomics and secretomics data are available in Supplementary Files 1 and 2 respectively. Custom code and notes are available at http://www.matebiro.com/software/motilisim

Article and author information

Author details

  1. Jorge Luis Galeano Niño

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Sophie V Pageon

    Medicine, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1701-5551
  3. Szun S Tay

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0186-8154
  4. Feyza Colakoglu

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Daryan Kempe

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Jack Hywood

    Sydney Medical School, The University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  7. Jessica K Mazalo

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. James Cremasco

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  9. Matt A Govendir

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  10. Laura F Dagley

    Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4171-3712
  11. Kenneth Hsu

    Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  12. Simone Rizzetto

    Medicine, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-3881-8759
  13. Jerzy Zieba

    School of Medical Sciences, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  14. Gregory Rice

    Department of Statistics and Actuarial Science, University of Waterloo, Waterloo, Canada
    Competing interests
    The authors declare that no competing interests exist.
  15. Victoria Prior

    Children's Cancer Research Unit, Kids Research, Westmead, Australia
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-2285-5398
  16. Geraldine M O'Neill

    Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  17. Richard J Williams

    School of Medicine, Deakin University, Melbourne, Australia
    Competing interests
    The authors declare that no competing interests exist.
  18. David R Nisbet

    Advanced Biomaterials Lab, Research School of Engineering, Australian National University, Canberra, Australia
    Competing interests
    The authors declare that no competing interests exist.
  19. Belinda Kramer

    Children's Cancer Research Unit, The Children's Hospital at Westmead, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  20. Andrew I Webb

    Advanced Technology and Biology Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
    Competing interests
    The authors declare that no competing interests exist.
  21. Fabio Luciani

    School of Medical Sciences, University of New South Wales, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  22. Mark N Read

    Charles Perkins Centre, University of Sydney, Sydney, Australia
    Competing interests
    The authors declare that no competing interests exist.
  23. Maté Biro

    Single Molecule Science node, School of Medical Sciences, EMBL Australia, Sydney, Australia
    For correspondence
    m.biro@unsw.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-5852-3726

Funding

National Sciences and Engineering Research Council Canada (RGPIN 50503-10477 and 50503-10476)

  • Gregory Rice

National Health and Medical Research Council (GNT1135687)

  • David R Nisbet

University of Sydney CoE in Advanced Food Enginomics

  • Mark N Read

EMBL Australia

  • Maté Biro

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Ethics

Animal experimentation: All animal breeding and experimentation were conducted in accordance with New South Wales state and Australian federal laws and animal ethics protocols overseen and approved by the University of New South Wales Animal Care and Ethics Committee (ACEC) under protocols 16/83B and 19/133B.

Human subjects: Human peripheral blood mononuclear cells (PBMCs) were obtained from healthy donors after informed consent and were used in experiments under a Human Research Ethics Committee (HREC) approved protocol (Sydney Children's Hospitals Network, LNR/13/SCHN/241).

Copyright

© 2020, Galeano Niño et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 8,747
    views
  • 948
    downloads
  • 62
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jorge Luis Galeano Niño
  2. Sophie V Pageon
  3. Szun S Tay
  4. Feyza Colakoglu
  5. Daryan Kempe
  6. Jack Hywood
  7. Jessica K Mazalo
  8. James Cremasco
  9. Matt A Govendir
  10. Laura F Dagley
  11. Kenneth Hsu
  12. Simone Rizzetto
  13. Jerzy Zieba
  14. Gregory Rice
  15. Victoria Prior
  16. Geraldine M O'Neill
  17. Richard J Williams
  18. David R Nisbet
  19. Belinda Kramer
  20. Andrew I Webb
  21. Fabio Luciani
  22. Mark N Read
  23. Maté Biro
(2020)
Cytotoxic T Cells swarm by homotypic chemokine signalling
eLife 9:e56554.
https://doi.org/10.7554/eLife.56554

Share this article

https://doi.org/10.7554/eLife.56554

Further reading

    1. Computational and Systems Biology
    2. Microbiology and Infectious Disease
    Ruihan Dong, Rongrong Liu ... Cheng Zhu
    Research Article

    Antimicrobial peptides (AMPs) are attractive candidates to combat antibiotic resistance for their capability to target biomembranes and restrict a wide range of pathogens. It is a daunting challenge to discover novel AMPs due to their sparse distributions in a vast peptide universe, especially for peptides that demonstrate potencies for both bacterial membranes and viral envelopes. Here, we establish a de novo AMP design framework by bridging a deep generative module and a graph-encoding activity regressor. The generative module learns hidden ‘grammars’ of AMP features and produces candidates sequentially pass antimicrobial predictor and antiviral classifiers. We discovered 16 bifunctional AMPs and experimentally validated their abilities to inhibit a spectrum of pathogens in vitro and in animal models. Notably, P076 is a highly potent bactericide with the minimal inhibitory concentration of 0.21 μM against multidrug-resistant Acinetobacter baumannii, while P002 broadly inhibits five enveloped viruses. Our study provides feasible means to uncover the sequences that simultaneously encode antimicrobial and antiviral activities, thus bolstering the function spectra of AMPs to combat a wide range of drug-resistant infections.

    1. Computational and Systems Biology
    2. Neuroscience
    Gabriel Loewinger, Erjia Cui ... Francisco Pereira
    Tools and Resources

    Fiber photometry has become a popular technique to measure neural activity in vivo, but common analysis strategies can reduce the detection of effects because they condense within-trial signals into summary measures, and discard trial-level information by averaging across-trials. We propose a novel photometry statistical framework based on functional linear mixed modeling, which enables hypothesis testing of variable effects at every trial time-point, and uses trial-level signals without averaging. This makes it possible to compare the timing and magnitude of signals across conditions while accounting for between-animal differences. Our framework produces a series of plots that illustrate covariate effect estimates and statistical significance at each trial time-point. By exploiting signal autocorrelation, our methodology yields joint 95% confidence intervals that account for inspecting effects across the entire trial and improve the detection of event-related signal changes over common multiple comparisons correction strategies. We reanalyze data from a recent study proposing a theory for the role of mesolimbic dopamine in reward learning, and show the capability of our framework to reveal significant effects obscured by standard analysis approaches. For example, our method identifies two dopamine components with distinct temporal dynamics in response to reward delivery. In simulation experiments, our methodology yields improved statistical power over common analysis approaches. Finally, we provide an open-source package and analysis guide for applying our framework.